Travere Therapeutics to Report First Quarter 2026 Financial Results

Go back to Travere Therapeutics to Report First Quarter 2026 Financial Results
(NASDAQ: TVTX) Delayed: 66.17 -1.34 (1.98%)
Previous Close $67.51    52 Week High
Open $67.76    52 Week Low
Day High $68.73    P/E N/A 
Day Low $66.11    EPS
Volume 1,149,753